Melissa Moles

Melissa Moles is Head of Clinical Operations at ModeX, responsible for the operational execution of novel multispecific therapeutics for immuno-oncology and infectious disease clinical trials. Melissa brings 25 years of clinical drug development expertise and operational execution to the company. She has a demonstrated record of leadership in guiding teams to quality execution of phase I to phase III global clinical trials in multiple indications including oncology, infectious, cardiovascular, and rare diseases. Prior to joining ModeX, Melissa held key roles as Vice President of Clinical Operations at Flare Therapeutics Inc., Infectious Disease Portfolio lead at BioNTech SE,  Head of Clinical Operations at Neon Therapeutics and Clinical Operations Group Head at Novartis Institute for Biomedical Research.

Melissa received a B.A. in biology from St. Anselm College.